DOV vs OTIS vs SYM
161 measures in 16 categories, one definition each, computed from filings and market data.
DOV57.6
Dover Corporation
Industrials · Industrial - Machinery
$195.80 +0.89%$26.4B mkt cap
Score DNA
OTIS54.1
Otis Worldwide Corporation
Industrials · Industrial - Machinery
$71.33 +1.34%$27.2B mkt cap
Score DNA
Price, rebased to 100 three years ago
DOV OTIS SYM · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 6 | 0 |
| Last Congress purchase | 2026-09-11 | 2026-08-27 | — |
| 13F net change in holders | +37 | −13 | +8 |
| ETFs adding shares, 30d | 979 | 1,011 | 177 |
| ETFs trimming, 30d | 835 | 926 | 116 |
| Net ETF funds, 30d | +144 | +85 | +61 |
Valuation
16 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| P/E (TTM) | 23.2x
24th
|
17.9x
13th
|
— |
| PEG (P/E ÷ 3-yr EPS CAGR) | 4.77
79th
|
2.52
66th
|
— |
| Price / sales | 3.1x
64th
|
1.8x
31st
|
10.6x
100th
|
| Price / book | 3.4x
47th
|
— | 39.5x
100th
|
| Price / tangible book | 44.4x
88th
|
— | 9.7x
44th
|
| Price / free cash flow | 22.5x
52nd
|
15.9x
16th
|
38.0x
91st
|
| Price / operating cash flow | 18.9x
57th
|
14.5x
29th
|
33.5x
93rd
|
| Enterprise value | $27.9B
82nd
|
$35.2B
85th
|
$26.3B
80th
|
| EV / sales | 3.3x
66th
|
2.4x
41st
|
9.9x
100th
|
| EV / EBITDA | 14.7x
39th
|
14.3x
36th
|
445.4x
100th
|
| EV / EBIT | 18.6x
30th
|
15.4x
15th
|
— |
| EV / free cash flow | 23.8x
41st
|
20.6x
29th
|
35.6x
82nd
|
| Earnings yield | 4.3%
79th
|
5.6%
89th
|
0.0%
10th
|
| FCF yield | 4.4%
52nd
|
6.3%
85th
|
2.6%
16th
|
| Operating cash flow yield | 5.3%
46th
|
6.9%
72nd
|
3.0%
11th
|
| Graham number (per share) | $103.46
80th
|
— | $3.37
0th
|
Profitability (TTM)
12 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Gross margin | 39.6%
69th
|
30.2%
34th
|
21.6%
11th
|
| EBITDA margin | 22.5%
79th
|
16.5%
48th
|
2.2%
10th
|
| Operating margin | 16.9%
67th
|
15.4%
62nd
|
1.2%
8th
|
| EBIT margin | 17.8%
72nd
|
15.3%
62nd
|
0.6%
10th
|
| Net margin | 13.5%
77th
|
10.2%
59th
|
0.5%
10th
|
| NOPAT margin | 13.5%
67th
|
11.7%
59th
|
1.3%
8th
|
| FCF margin | 13.9%
69th
|
11.5%
52nd
|
27.9%
97th
|
| Operating cash flow margin | 16.5%
64th
|
12.5%
39th
|
31.6%
97th
|
| R&D / revenue | 0.5%
56th
|
1.0%
64th
|
7.4%
97th
|
| SG&A / revenue | 22.7%
70th
|
13.7%
25th
|
12.9%
18th
|
| Stock comp / revenue | 0.5%
33rd
|
0.2%
17th
|
5.4%
100th
|
| Effective tax rate | 20.1%
32nd
|
23.9%
75th
|
-0.7%
5th
|
Returns on capital
11 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| ROE (on average equity) | 15.0%
61st
|
— | 2.7%
10th
|
| ROA | 8.5%
67th
|
14.0%
90th
|
0.5%
10th
|
| ROIC | 12.3%
59th
|
76.2%
98th
|
-3.3%
7th
|
| ROCE | 13.4%
64th
|
78.1%
100th
|
1.2%
10th
|
| Return on tangible assets | 11.2%
62nd
|
21.1%
97th
|
0.6%
10th
|
| Cash ROIC (OCF / invested capital) | 15.1%
60th
|
81.9%
97th
|
— |
| Gross profitability (GP / assets) | 24.3%
48th
|
40.3%
95th
|
16.2%
13th
|
| ROIC, 3-yr average | 17.1%
86th
|
158.9%
100th
|
— |
| ROIC, 5-yr average | 19.6%
83rd
|
— | — |
| ROE, 5-yr average | 24.3%
87th
|
— | -488.5%
0th
|
| Incremental ROIC | -153.8%
14th
|
173.1%
88th
|
8.3%
37th
|
Growth
17 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Revenue growth (TTM YoY) | 7.6%
53rd
|
5.2%
42nd
|
20.6%
88th
|
| Revenue growth (QoQ) | 6.6%
36th
|
8.2%
43rd
|
6.6%
34th
|
| Revenue CAGR, 3 yr | -0.2%
17th
|
2.5%
37th
|
37.0%
100th
|
| Revenue CAGR, 5 yr | 2.5%
16th
|
1.5%
7th
|
78.5%
100th
|
| Gross profit CAGR, 3 yr | 3.1%
29th
|
3.6%
36th
|
48.9%
100th
|
| Operating income CAGR, 3 yr | 1.4%
24th
|
2.2%
27th
|
— |
| Net income growth (TTM YoY) | -50.5%
10th
|
0.2%
53rd
|
— |
| Net income CAGR, 3 yr | 3.6%
51st
|
4.5%
53rd
|
— |
| EPS growth (TTM YoY) | -49.6%
12th
|
3.0%
53rd
|
— |
| EPS CAGR, 3 yr | 4.9%
53rd
|
7.1%
55th
|
— |
| EPS CAGR, 5 yr | 6.7%
46th
|
8.0%
54th
|
— |
| FCF growth (TTM YoY) | 110.8%
94th
|
27.0%
71st
|
326.8%
98th
|
| FCF CAGR, 3 yr | 12.2%
43rd
|
9.4%
32nd
|
90.2%
96th
|
| Operating cash flow CAGR, 3 yr | 10.2%
45th
|
9.5%
38th
|
83.8%
96th
|
| Book value CAGR, 3 yr | 19.7%
88th
|
— | 410.1%
100th
|
| Dividend CAGR, 3 yr | 1.0%
36th
|
4.0%
78th
|
-22.6%
0th
|
| Sustainable growth rate | 11.3%
56th
|
— | 2.5%
11th
|
Margin history & stability
7 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Gross margin, 3-yr average | 38.8%
65th
|
30.2%
35th
|
18.3%
5th
|
| Operating margin, 3-yr average | 16.4%
68th
|
15.1%
60th
|
-4.3%
3rd
|
| Net margin, 3-yr average | 20.6%
98th
|
10.4%
55th
|
-0.5%
7th
|
| FCF margin, 3-yr average | 11.6%
57th
|
9.9%
42nd
|
13.2%
68th
|
| Revenue stability (0-1) | 0.32
17th
|
0.68
32nd
|
1.00
98th
|
| Earnings stability (0-1) | 0.29
37th
|
0.94
97th
|
0.72
73rd
|
| Margin stability (0-1) | 0.96
73rd
|
0.98
92nd
|
0.45
0th
|
Liquidity (latest quarter)
7 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Cash & short-term investments | $1.8B
93rd
|
$813.0M
80th
|
$1.7B
92nd
|
| Net cash (− = net debt) | −$1.5B
39th
|
−$8.0B
5th
|
$1.7B
98th
|
| Working capital | $2.4B
97th
|
−$1.4B
2nd
|
$710.7M
64th
|
| Current ratio | 1.98
41st
|
0.83
0th
|
1.33
20th
|
| Quick ratio | 1.41
66th
|
0.75
11th
|
1.23
54th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.70
79th
|
0.10
11th
|
0.81
84th
|
| Defensive interval (days) | 625 days
70th
|
929 days
90th
|
1,691 days
97th
|
Leverage & solvency (latest quarter)
13 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Total debt | $3.3B
79th
|
$8.8B
93rd
|
$25.8M
8th
|
| Debt / equity | 0.42
33rd
|
— | 0.04
10th
|
| Net debt / equity | 0.20
30th
|
— | −2.43
0th
|
| Debt / assets | 23.8%
38th
|
79.3%
100th
|
0.7%
3rd
|
| Debt / capital | 29.7%
33rd
|
— | 3.5%
10th
|
| Debt / EBITDA | 1.72
39th
|
3.60
75th
|
0.44
12th
|
| Net debt / EBITDA | 0.79
30th
|
3.27
84th
|
−29.18
0th
|
| Interest coverage (EBIT / interest) | 13.2x
71st
|
10.9x
61st
|
— |
| Cash interest coverage | 12.2x
73rd
|
8.9x
57th
|
— |
| Debt payback (years of OCF) | 2.3 yrs
43rd
|
4.7 yrs
72nd
|
0.0 yrs
3rd
|
| Liabilities / assets | 43.7%
23rd
|
149.8%
100th
|
67.8%
84th
|
| IS credit model rating | AA- | B- | A |
| Implied credit spread (bps) | 100
21st
|
900
98th
|
150
54th
|
Efficiency
11 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Asset turnover | 0.63
38th
|
1.38
97th
|
0.99
69th
|
| Fixed asset turnover | 7.56
74th
|
11.17
93rd
|
16.68
100th
|
| Inventory turnover | 3.7
56th
|
16.2
100th
|
11.5
98th
|
| Receivables turnover | 5.6
41st
|
3.5
3rd
|
12.5
100th
|
| Days sales outstanding | 65 days
59th
|
103 days
97th
|
29 days
0th
|
| Days inventory outstanding | 98 days
44th
|
23 days
0th
|
32 days
2nd
|
| Days payables outstanding | 65 days
75th
|
67 days
77th
|
48 days
39th
|
| Cash conversion cycle (days) | 97 days
33rd
|
59 days
5th
|
13 days
0th
|
| Capex / revenue | 2.6%
60th
|
1.1%
2nd
|
3.7%
82nd
|
| Capex / depreciation | 0.56
38th
|
0.92
72nd
|
2.32
98th
|
| Operating expense ratio | 22.3%
59th
|
14.5%
18th
|
17.8%
34th
|
Cash flow & earnings quality
7 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Operating cash flow / net income | 1.23
27th
|
1.23
29th
|
66.26
100th
|
| FCF / net income | 1.03
31st
|
1.13
38th
|
58.42
100th
|
| FCF / operating cash flow | 84.3%
54th
|
91.5%
88th
|
88.2%
72nd
|
| Capex / operating cash flow | 15.7%
46th
|
8.5%
12th
|
11.8%
28th
|
| Accruals ratio | -1.9%
70th
|
-3.3%
51st
|
-30.8%
2nd
|
| Sloan accruals ratio | 0.0%
64th
|
-6.5%
10th
|
20.9%
95th
|
| Earnings quality score (0-1) | 1.00
25th
|
1.00
25th
|
0.75
4th
|
Scores & forensic checks
15 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| IS score | 58
48th
|
54
43rd
|
66
77th
|
| IS profitability | 55
66th
|
41
44th
|
13
5th
|
| IS growth | 28
15th
|
54
67th
|
72
93rd
|
| IS value | 49
57th
|
50
62nd
|
35
13th
|
| IS momentum | 59
20th
|
73
50th
|
97
98th
|
| IS risk (safety) | 100
48th
|
65
23rd
|
50
7th
|
| IS quality | 78
79th
|
60
21st
|
67
39th
|
| IS balance sheet | 77
79th
|
40
8th
|
78
84th
|
| IS earnings quality | 77
80th
|
68
23rd
|
35
5th
|
| IS cash flow | 69
74th
|
64
61st
|
94
98th
|
| Piotroski F-score (0-9) | 7
61st
|
5
20th
|
6
36th
|
| Altman Z-score | 5.7
70th
|
2.8
28th
|
1.9
8th
|
| Beneish M-score | −2.56
45th
|
−2.52
52nd
|
−2.83
8th
|
| Ohlson O-score | −8.84
21st
|
−3.68
100th
|
−7.58
57th
|
| IS credit score | 85
79th
|
20
2nd
|
75
46th
|
Size (TTM)
8 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| Market cap | $26.4B
80th
|
$27.2B
82nd
|
$28.0B
84th
|
| Revenue | $8.4B
82nd
|
$14.9B
87th
|
$2.6B
49th
|
| EBITDA | $1.9B
84th
|
$2.5B
87th
|
$59.0M
15th
|
| Net income | $1.1B
84th
|
$1.5B
89th
|
$12.6M
13th
|
| Free cash flow | $1.2B
82nd
|
$1.7B
87th
|
$737.3M
77th
|
| Total assets | $13.7B
82nd
|
$11.2B
80th
|
$3.5B
49th
|
| Shareholders' equity | $7.7B
85th
|
−$5.7B
0th
|
$708.8M
30th
|
| Employees | 24,000
82nd
|
72,000
98th
|
2,000
13th
|
Price performance
9 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| 1 day | +0.9% | +1.3% | −2.5% |
| 1 week | +3.7% | +8.2% | −9.1% |
| 1 month | +3.5% | +3.8% | −13.1% |
| 3 months | −6.6% | −2.9% | −5.0% |
| 6 months | −10.6% | −12.4% | −38.6% |
| Year to date | +0.3% | −18.9% | −40.2% |
| 1 year | +20.7% | −21.6% | −48.5% |
| 3 years, cumulative | +41.4% | −8.6% | −7.3% |
| 5 years, cumulative | +31.0% | −8.7% | +293.6% |
Technicals
4 measures| Measure | DOV | OTIS | SYM |
|---|---|---|---|
| RSI 14 | 59.5 | 65.0 | 40.1 |
| From 52-week high | −17.4% | −24.6% | −55.9% |
| From 52-week low | +20.2% | +12.2% | +6.3% |
| Beta | 1.13 | 0.86 | 1.97 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17